Albert Folch

The paper introduces a bioprinting method to precisely place and immobilize microdissected tumor cuboids in hydrogels for drug testing and protein analysis.

This paper presents a low-cost robotic platform for manipulating live microtissues to enable cancer drug testing using patient biopsies on 384-well plates.

This study develops a microfluidic platform to perfuse microdissected tumors, showing improved microvascular structure and CD31 expression compared to diffusive transport.

The paper develops a microscale ex vivo cancer model using tumor cuboids that retain a complex tumor microenvironment, enabling drug and immunotherapy testing.